论文部分内容阅读
2011年9月22日,美国食品药品管理局(FDA)宣布含氯氟烃(CFCs)的肾上腺素吸入剂于2011年12月31日停产或停售,患者应计划寻求替代产品治疗。Armstrong制药公司Primatene Mist肾上腺素吸入剂是唯一获FDA批准的暂时缓解轻度哮喘偶然发作
On September 22, 2011, the U.S. Food and Drug Administration announced that adrenaline inhalers for chlorofluorocarbons (CFCs) were discontinued or discontinued on December 31, 2011 and patients should plan to seek alternative treatment. Armstrong Pharmaceuticals Primatene Mist Adrenergic Inhaler is the only FDA-approved temporary relief mild respiratory attack